SALT
LAKE CITY, March 11, 2025 /PRNewswire/ -- Health
Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading
provider of data and analytics technology and services to
healthcare organizations, today announced it has repurchased shares
of its common stock ("Common Stock") in an aggregate amount of
approximately $5 million.
These repurchased shares were acquired between March 3, 2025, and March
10, 2025, as part of Health Catalyst's existing share
repurchase program approved by its board of directors on
August 2, 2022, which authorized
repurchases of up to $40 million of
Common Stock. These recent repurchases resulted in the retirement
of approximately 1.1 million shares of Common Stock.
"Our repurchase of shares underscores our confidence in the
future of our business," said Dan
Burton, CEO of Health Catalyst. "We believe the current
market does not reflect the long-term value of our shares of common
stock, including our anticipated continued achievement of operating
leverage and our reacceleration of revenue growth. This
repurchase demonstrates our continued commitment to creating
long-term, sustainable value for our shareholders, our clients, and
our team members."
About Health Catalyst
Health Catalyst (Nasdaq: HCAT)
is a leading provider of data and analytics technology and services
that ignite smarter healthcare, lighting the path to measurable
clinical, financial, and operational improvement. More than 1,000
organizations worldwide rely on Health Catalyst's offerings,
including our cloud-based technology ecosystem Health Catalyst
Ignite™, AI-enabled data and analytics solutions, and expert
services to drive meaningful outcomes across hundreds of millions
of patient records. Powered by high-value data, standardized
measures and registries, and deep healthcare domain expertise,
Ignite helps organizations transform complex information into
actionable insights. Backed by a multi-decade mission and a proven
track record of delivering billions of dollars in measurable
results, Health Catalyst continues to serve as the catalyst for
massive, measurable, data-informed healthcare improvement and
innovation.
Forward-Looking Statements
This release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, Section 21E of the Securities
Exchange Act of 1934, as amended, and the Private Securities
Litigation Reform Act of 1995, as amended, including statements
relating to Health Catalyst's operating leverage, revenue growth
and stock performance. All statements contained in this press
release that do not relate to matters of historical fact should be
considered forward-looking statements, including without limitation
statements regarding Health Catalyst's future performance and
opportunities. These forward-looking statements represent Health
Catalyst's expectations as of the date of this press release, and
involve risks, uncertainties and assumptions. The actual results
may differ materially from those anticipated in the forward-looking
statements as a result of numerous factors, many of which are
beyond Health Catalyst's control. Important risks and uncertainties
that could cause Health Catalyst's actual results and financial
condition to differ materially from those indicated in the
forward-looking statements include, among others, the following:
(i) changes in laws and regulations applicable to Health Catalyst's
business model; (ii) changes in market or industry conditions,
regulatory environment, and receptivity to Health Catalyst's
technology and services; (iii) results of litigation or a security
incident; (iv) the loss of one or more key clients or partners; (v)
macroeconomic challenges (including high inflationary and/or high
interest rate environments, or market volatility caused by bank
failures and measures taken in response thereto) and any new public
health crisis; and (vi) changes to Health Catalyst's abilities to
recruit and retain qualified team members. For a detailed
discussion of the risk factors that could affect Health Catalyst's
actual results, please refer to the risk factors identified in
Health Catalyst's SEC reports, including, but not limited to the
Annual Report on Form 10-K for the year ended December 31, 2024 filed on February 26, 2025, available at www.sec.gov.
While Health Catalyst may elect to update such forward-looking
statements at some point in the future, Health Catalyst disclaims
any obligation to do so, even if subsequent events cause Health
Catalyst's views to change.
Investor Relations Contact:
Jack Knight
Vice President, Investor Relations
+1 (855)-309-6800
ir@healthcatalyst.com
Media Contact:
Kathryn
Mykleseth
PR and Communications Director
media@healthcatalyst.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/health-catalyst-announces-5-million-stock-repurchase-302397725.html
SOURCE Health Catalyst
